Labcorp is Set to Acquire Select Assets of BioReference Health of OPK

Labcorp (LH) recently entered into an agreement with OPKO Health, Inc. (OPK) , a multinational biopharmaceutical and diagnostics company, to acquire select assets of the latter’s wholly owned subsidiary, BioReference Health. This acquisition will strengthen Labcorp's position in the oncology industry, expanding its extensive portfolio of diagnostic tests in cancer care. Financial DetailsThe purchase price for the transaction is up to $225 million, including$192.5 million payable at closing and up to $32.5 ...